Literature DB >> 22580917

Life-threatening Escherichia coli cellulitis in patients with haematological malignancies.

S Sunder1,2, E Haguenoer3,1, D Bouvet3,1, S Lissandre4, A Bree5, D Perrotin6,1, E Helloin5, P Lanotte3,1, C Schouler5, A Guillon6,1.   

Abstract

Cellulitis due to Escherichia coli is rare and usually secondary to a cutaneous portal of entry. Skin and soft tissue infections (SSTI) secondary to E. coli bacteraemia have been reported exclusively in immunodeficient patients. Here, we report two cases of serious cellulitis secondary to E. coli bacteraemia in patients with haematological malignancies. Both isolated strains belonged to phylogenetic group B2 and harboured some of the main virulence factor genes commonly found in extra-intestinal pathogenic E. coli (ExPEC), including neuC, iro and fimH. Cellulitis due to E. coli seems to be linked to the immunocompromised status of patients rather than to a highly virulent clone. Nevertheless, some of the virulence factors appear to be important because both isolates belong to phylogenetic group B2. This aetiology should be considered in SSTI in patients with haematological malignancies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580917     DOI: 10.1099/jmm.0.042366-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  2 in total

1.  Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.

Authors:  Ruaridh Buchanan; Nicole Stoesser; Derrick Crook; Ian C J W Bowler
Journal:  BMJ Case Rep       Date:  2014-10-19

2.  Cancer patients with neutropenic septic shock: etiology and antimicrobial resistance.

Authors:  Sung Min Jung; Youn Jung Kim; Seung Mok Ryoo; Chang Hwan Sohn; Dong Woo Seo; Kyoung Soo Lim; Won Young Kim
Journal:  Korean J Intern Med       Date:  2019-10-28       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.